Endothelial swelling can compress capillaries and reduce the space available for blood to pass through the microcirculation. At the same time, leukocyte adhesion, platelet aggregation, and microthrombi add physical obstructions. Because these changes affect vessels below the reopened artery, they can preserve a tissue-level perfusion deficit even when the upstream occlusion has been relieved.
Restoration of flow in a large artery addresses the original blockage but does not guarantee passage through compressed or obstructed capillaries. The resulting mismatch means oxygen may remain poorly delivered to cells, while metabolites are not efficiently cleared. This distinction makes tissue-level microvascular assessment important when judging whether reperfusion has fully benefited the affected region.
Leukocytes can adhere to the endothelium, platelets can aggregate, and microthrombi can occupy or obstruct narrow microvessels. Together, these processes increase resistance to flow at the capillary level and reinforce the effects of endothelial swelling and compression. Their contribution helps explain why reopening the main vessel may leave downstream circulation inadequate and cellular injury ongoing.
Ischemia-reperfusion injury does not end automatically when an occluded artery is reopened. If swelling, cellular adhesion, aggregation, and microthrombi continue to impede microvessels, oxygen delivery and metabolite clearance remain compromised. The No-reflow Phenomenon therefore represents an important microvascular feature of reperfusion injury and a mechanism through which tissue damage may be extended.
Imaging approaches can help examine whether restored circulation reaches the microvascular level rather than stopping at the reopened large vessel. In this context, they support investigation of persistent perfusion deficits after reperfusion and evaluation of strategies intended to restore tissue perfusion. Their importance lies in connecting vascular reopening with the biological condition of the affected tissue.
The phenomenon is relevant after myocardial infarction, ischemic stroke, and organ transplantation, because each setting can involve restoration of flow after ischemic injury. Studying these contexts helps biology and medicine examine why apparent reperfusion may not normalize microvascular circulation and why tissue injury can persist despite treatment of the major vascular obstruction.
Successful reopening demonstrates that flow has returned through the previously occluded large vessel, but it does not by itself prove adequate perfusion of downstream tissue. Persistent no-reflow signals continuing microvascular dysfunction, with possible limitations in oxygen delivery and metabolite clearance. Clinical and experimental interpretation should therefore distinguish large-vessel patency from effective tissue perfusion.